Skip to content

Study on the Mechanism of Regulating Intestinal Microecology by multigrain noodles on Glucose Metabolism in Patients with Type 2 Diabetes Mellitus

Study on the Mechanism of Regulating Intestinal Microecology by multigrain noodles on Glucose Metabolism in Patients with Type 2 Diabetes Mellitus

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300068505
Enrollment
Unknown
Registered
2023-02-21
Start date
2022-09-30
Completion date
Unknown
Last updated
2023-05-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 2 diabetes

Interventions

A group:multigrain noodles intervention for 2 weeks + general diet for 2 weeks with a washout period of 2 weeks.
B group:general diet for 2 weeks + multigrain noodles intervention for 2 weeks with a washout period of 2 weeks.

Sponsors

Shanghai Changzheng Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Patients with type 2 diabetes; 2. Patients aged from 18 to 80 years old; 3. At the first visit,HbA1c < 9.0%.

Exclusion criteria

Exclusion criteria: 1. Patients who have changed the use of hypoglycemic drugs within 3 months prior to enrollment; 2. Patients with severe hepatic and renal impairment and autoimmune diseases, malignancy, gastrointestinal diseases, history of gastrointestinal surgery; 3. Patients with acute and critical illnesses such as severe infection, ketoacidosis, diabetic hyperosmolarity; 4. Pregnant or lactating women; 5. Patients who drinked yogurt in the past 7 days or ingestion of fermented products during the trial; 6. Patients who use antibiotics, micro-ecological modulators, gastrointestinal motility drugs and other agents affecting the intestinal flora within the past 3 months; 7. Patients with severe mental illness, poor compliance in the past 6 months; 8. Alcohol abuse; 9. Patients who have participated in other research projects in the past 3 months.

Design outcomes

Primary

MeasureTime frame
Glycosylated hemoglobin, HbA1c;fasting blood sugar, FPG;Diurnal glycemic excursion;

Secondary

MeasureTime frame
fasting insulin, FINS;fasting c-peptide, FCP;total cholesterol, TC;Triglycerides, TG;High-density lipoprotein, HDL;Low-density lipoprotein, LDL;Intestinal flora;Interleukin-1ß;Interleukin-6;Interleukin-10;Tumor necrosis factor-alpha;

Countries

China

Contacts

Public ContactLi Juan

Shanghai Changzheng Hospital

yyk3020@163.com+86 139 1795 7979

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026